Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.6K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.6K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.4K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

367
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
367

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Epigenetics as a mechanism of lineage extinction and relapse of B-cell lymphoma treated with CD19 CAR T-cell therapy.

Blood neoplasia·2026
Same author

Development and Validation of Artificial Intelligence Prediction of Epicardial Coronary Artery Spasm in Patients Without Obstructive Coronary Artery Disease.

Diagnostics (Basel, Switzerland)·2026
Same author

From breadth to depth in clinical artificial intelligence evaluation.

Nature biomedical engineering·2026
Same author

Effects of Left Atrial Wall Thickness on Myocardial Mechanics and Blood Dynamics using Multiscale Modeling.

bioRxiv : the preprint server for biology·2026
Same author

CD48 expression in T-lymphoblastic leukemia/lymphoma and mature T-cell neoplasms: role in detecting measurable residual disease and potential confounders, a single-institution retrospective review.

American journal of clinical pathology·2026
Same author

Single-cell and spatial transcriptomics identify immune-stromal interactions in cardiac allograft vasculopathy.

Nature cardiovascular research·2026

相关实验视频

Updated: Jan 18, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

15.0K

免疫抑制药物对内皮细胞功能表现出不同的影响.

Aly Elezaby1,2, Ryan Dexheimer1, David Wu1,3

  • 1Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.

Journal of vascular research
|September 11, 2025
PubMed
概括

常见的免疫抑制药物sirolimus和tacrolimus对内皮细胞功能的影响不同. 西洛利斯会影响细胞迁移和线粒体呼吸,而塔克罗利斯会影响氧化的释放,从而显示出药物特定的血管作用.

关键词:
内皮细胞的功能是内皮细胞功能.免疫抑制是一种免疫抑制.移植 移植 移植 移植血管改造是指进行血管改造.

更多相关视频

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.9K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.9K

相关实验视频

Last Updated: Jan 18, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

15.0K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.9K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.9K

科学领域:

  • 血管生物学 血管生物学
  • 免疫学 免疫学 免疫学
  • 干细胞生物学 干细胞生物学

背景情况:

  • 免疫抑制药物对于管理瘤,自身免疫性疾病和器官移植至关重要.
  • 众所周知,这些药物可以诱导不良的血管改造.
  • 系统性药物效应使理解细胞类型对血管系统的特定影响变得复杂.

研究的目的:

  • 研究免疫抑制药物对内皮细胞功能的影响.
  • 使用新型模型阐明细胞类型特定的药物影响.

主要方法:

  • 使用诱导多能干细胞衍生的内皮细胞 (iPSC-ECs).
  • 评估内皮细胞功能,包括迁移,增殖,LDL吸收,线粒体呼吸和氧化释放.

主要成果:

  • 赛洛斯显著降低了内皮细胞迁移,增殖,乙化LDL吸收,线粒体呼吸和血管性质.
  • 发现塔克罗利斯可以减少氧化的释放,与西罗利斯相比,对其他功能的影响较小.

结论:

  • 该iPSC-EC模型有效地区分了免疫抑制药物对内皮功能的影响.
  • 这些发现有助于阐明药物诱导的不良血管形状背后的机制.
  • 这项研究为治疗免疫抑制剂患者的血管并发症提供了洞察力.